Kohjin Bio Co (TSE:177A) Beginning Cash Position : 円0 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Kohjin Bio Co Beginning Cash Position?

Kohjin Bio Co's Beginning Cash Position for the quarter that ended in Sep. 2024 was 円0 Mil.

Kohjin Bio Co's annual Beginning Cash Position increased from Mar. 2022 (円1,220 Mil) to Mar. 2023 (円1,734 Mil) but then declined from Mar. 2023 (円1,734 Mil) to Mar. 2024 (円1,463 Mil).

Kohjin Bio Co Beginning Cash Position Historical Data

The historical data trend for Kohjin Bio Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kohjin Bio Co Beginning Cash Position Chart

Kohjin Bio Co Annual Data

Trend

Mar22

Mar23

Mar24

Beginning Cash Position

1,219.70

1,734.49

1,462.57

Kohjin Bio Co Quarterly Data
	Mar22	Mar23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial			-	-	-	-	-

Kohjin Bio Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Kohjin Bio Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Kohjin Bio Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kohjin Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kohjin Bio Co Ltd (TSE:177A) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214

Website

https://www.kohjin-bio.jp/en

Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

Kohjin Bio Co Headlines

No Headlines